This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

10/31/14 - 06:40 AM EDT

Aegerion Problems Mount With Poor Quarter and Reduced Guidance

  • Tickers in this article:
  • AEGR

The accusations of cocaine use and having sex with someone else's wife are the least of Marc Beer's problems. Aegerion Pharmaceuticals, the company he runs as CEO, is falling apart.

10/30/14 - 05:07 PM EDT

Bristol-Myers Squibb (BMY) Stock Is Gaining on Positive Phase 2 Results

Bristol-Myers Squibb (BMY) Stock Is Gaining on Positive Phase 2 Results

  • Tickers in this article:
  • BMY

Bristol-Myers Squibb (BMY) shares are climbing after its lung cancer treatment showed positive phase 2 test results.

10/30/14 - 02:30 PM EDT

Cramer: Don't Sell U.S. Steel or Gilead Sciences on Earnings

Cramer: Don't Sell U.S. Steel or Gilead Sciences on Earnings

  • Tickers in this article:
  • X
  • GILD

TheStreet's Jim Cramer said U.S. Steel is a great comeback story, while investors shouldn't give up on Gilead Sciences following its earnings report.

10/29/14 - 10:53 AM EDT

Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations

Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations

  • Tickers in this article:
  • AEGR

Aegerion Pharmaceuticals issued a statement Tuesday night expressing its board's support for CEO Marc Beer in the face of accusations of cocaine use and extramarital sex.

10/29/14 - 09:16 AM EDT

October 29 Premarket Briefing: 10 Things You Should Know

October 29 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed ahead of a rates announcement from the Federal Reserve; Facebook's earnings top forecasts; Deutsche Bank posts a loss and ousts its CFO.

10/29/14 - 07:19 AM EDT

Arena Skimps on Data Disclosure From Weight-Loss Combo Study

Arena Skimps on Data Disclosure From Weight-Loss Combo Study

Arena Pharmaceuticals provided very little useful information Tuesday night about the Belviq-phentermine weight-loss combination.

10/29/14 - 07:30 AM EDT

Laboratory Corp. of America (LH) Higher After Earnings Beat

Laboratory Corp. of America (LH) Higher After Earnings Beat

  • Tickers in this article:
  • LH

Laboratory Corp. of America (LH) shares closed trading up after the company beat analysts earnings expectations and raised its revenue growth guidance for the year.

10/28/14 - 04:05 PM EDT

Washington Post’s Pearlstein Didn't Intend to Disparage TheStreet’s Integrity

Washington Post’s Pearlstein Didn't Intend to Disparage TheStreet’s Integrity

  • Tickers in this article:
  • TST
  • NWBO

Steven Pearlstein, columnist for the Washington Post, says he never meant to disparage TheStreet's editorial standards in his Sept. 27 column examining TheStreet's Northwest Bio coverage.

10/28/14 - 02:32 PM EDT

Eli Lilly (LLY) Stock Fails to Benefit From Positive Court Ruling

Eli Lilly (LLY) Stock Fails to Benefit From Positive Court Ruling

  • Tickers in this article:
  • LLY

Eli Lilly (LLY) shares are declining despite a positive court ruling today that significantly reduced its liability in a lawsuit over the side effects of its diabetes drug treatment, Actos.

10/28/14 - 01:03 PM EDT

Amgen (AMGN) Stock Is Climbing Today Following Earnings Release

Amgen (AMGN) Stock Is Climbing Today Following Earnings Release

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are climbing after the biotech company beat earnings estimates, raised its quarterly dividend, and provided strong full year guidance.

10/28/14 - 12:24 PM EDT

What to Watch on Wall Street for Tuesday, October 28th 2014

On Tuesday, October 28th we'll get one of the week's highest profile earnings reports as social networking giant, Facebook takes the spotlight.

10/27/14 - 07:00 PM EDT

Stock Market Today: Futures Pare Gains as Durable Goods Fall, Home Prices Rise

Stock Market Today: Futures Pare Gains as Durable Goods Fall, Home Prices Rise

U.S. stock futures pared gains after durable goods orders for September fell, missing expectations of a rise. A slightly better-than-expected read on nationwide home prices did little to impact markets.

10/28/14 - 09:18 AM EDT

Divorce Suit Names CEOs Involved in Cocaine Use, Extramarital Sex Romps

A dirty divorce for one of Wall Street's top bankers just got messier.

10/27/14 - 12:49 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,195.42 +221.11 1.30%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,566.1380 +16.9120 0.37%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs